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Next-generation sequencing (NGS) has the potential to provide typing results and detect resistance genes in a single assay, thus
guiding timely treatment decisions and allowing rapid tracking of transmission of resistant clones. We evaluated the perfor-
mance of a new NGS assay (Hospital Acquired Infection BioDetection System; Pathogenica) during an outbreak of sequence type
131 (ST131) Escherichia coli infections in a nursing home in The Netherlands. The assay was performed on 56 extended-spec-
trum-beta-lactamase (ESBL) E. coli isolates collected during 2 prevalence surveys (March andMay 2013). Typing results were
compared to those of amplified fragment length polymorphism (AFLP), whereby we visually assessed the agreement of the Bio-
Detection phylogenetic tree with clusters defined by AFLP. Amicroarray was considered the gold standard for detection of resis-
tance genes. AFLP identified a large cluster of 31 indistinguishable isolates on adjacent departments, indicating clonal spread.
The BioDetection phylogenetic tree showed that all isolates of this outbreak cluster were strongly related, while the further ar-
rangement of the tree also largely agreed with other clusters defined by AFLP. The BioDetection assay detected ESBL genes in all
but 1 isolate (sensitivity, 98%) but was unable to discriminate between ESBL and non-ESBL TEM and SHV beta-lactamases or to
specify CTX-M genes by group. The performance of the hospital-acquired infection (HAI) BioDetection System for typing of E.
coli isolates compared well with the results of AFLP. Its performance with larger collections from different locations, and for
typing of other species, was not evaluated and needs further study.
Genes encoding extended-spectrum beta-lactamases (ESBL)are rapidly spreading among Gram-negative bacteria. Due to
growing reservoirs of resistant Enterobacteriaceae in humans and
farm animals and the widespread presence of these bacteria in the
food chain, the frequency of outbreaks in hospitals and long-
term-care facilities is expected to increase (1–6). Nosocomial
spread of resistant bacteria poses a serious threat to patient safety
all around the world.
When an outbreak is detected, rapid assessment of its extent
and the identification of transmission routes and sources are es-
sential to prevent further transmission among susceptible pa-
tients. Several molecular typing methods are available to investi-
gate the degree of relatedness of strains recovered from patients
during outbreaks. Due to differences in performance (e.g., dis-
criminatory power and reproducibility), none of these typing
methods can be universally applied for all pathogens in all situa-
tions. Ideally, typing results should be reproducible so that all data
generated by different laboratories can be compared. Costs, time
to result, and the required level of technical skills are further de-
terminants of whether a typing method is suitable to be widely
implemented in microbiology laboratories (7, 8).
Amplified fragment length polymorphism (AFLP) is often
used for typing of Enterobacteriaceae. This technique relies on
amplification of genomic fragments generated by one or two re-
striction enzymes and uses the amplified products to create digi-
tized profiles. It has good discriminatory power but is relatively
expensive and time-consuming and is technically demanding.
Whole-genome sequencing (WGS) can provide information
about bacterial relatedness with across-genome single-nucleotide
resolution, but rapid translation of these data into epidemiologi-
cally useful information remains difficult. Data derived from
whole-genome sequencing have nonetheless facilitated the search
for suitable targets that allow bacterial typing based on sequencing
only a part of the genome. In addition to providing information
on phylogenetic relatedness, sequence data can be used to detect
resistance genes, enabling clinicians to rapidly track transmission
of resistant clones or mobile genetic elements and to initiate
timely appropriate treatment during outbreak situations. Thus, it
is likely that sequence-based typing methods will eventually re-
place fragment-based methods such as AFLP.
Next-generation sequencing (NGS) is a new high-throughput
sequencing method that can rapidly generate millions of reads
(ranging between 35 and 700 bp in length) at relatively low per-
base sequencing costs. The Hospital Acquired Infection BioDetec-
tion System (Pathogenica) is a new commercial NGS-based assay
that targets a selection of short DNA regions and is able to detect
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the presence of several different pathogens and resistance genes
simultaneously in a single sample while sequencing only a few
kilobases of genome. In addition, the kit includes software that can
be used to type the strains and provide a phylogenetic tree for sets
of isolates.
In June to July 2012, a survey in 9 nursing homes in the south-
ern region of The Netherlands identified several facilities with a
high prevalence of fecal ESBL carriage. The results of multilocus
sequence typing (MLST) and AFLP analysis of isolates collected in
the two facilities with the highest prevalences (19% and 21% rectal
carriage, respectively) indicated clonal spread in both facilities.
Widespread dissemination of E. coli ST131 (a multiresistant clone
that spreads extensively in elderly populations in regions of hyper-
endemicity all around the world) was found in one of the facilities.
In 2013, two follow-up surveys were performed to assess the effect
of the implemented interventions. In this paper, we compare the
typing performance of the new NGS assay to that of AFLP for the
isolates collected during these follow-up surveys.
MATERIALS AND METHODS
Isolate collection and epidemiological setting. Two consecutive cross-
sectional surveys were performed in March and May 2013. During these
surveys, feces or rectal swabs (Eswab medium; Copan Diagnostics) were
collected from all admitted patients, and hand cultures were taken from
health care workers (HCW). Every first ESBL-positive E. coli isolate per
patient or health care worker (collected either in March or in May) was
included in the isolate collection for the current study. The isolate collec-
tion thus included 56 E. coli isolates from 48 patients and 1 HCW. Forty-
nine isolates (from 42 patients and 1 HCW) were collected in the first
nursing home (NH1), and the remaining isolates were collected from the
second location (NH2) located at a 45-km distance from NH1. In NH1,
patients were residing in 3 semiseparate buildings (A, B, and C); each of
these buildings was divided into 2 or 3 separate departments (A1 to A3, B1
to B3, and C1 to C3). The study included 15, 20, and 14 isolates from
buildings A, B, and C, respectively. Staff members were not exchanged
between these buildings, and transfer of patients between departments
seldom occurred. From NH2, 7 isolates (from 6 patients residing in de-
partments D1 and D2) were included in the collection.
Identification and detection of resistance genes. Identification of
Gram-negative bacteria growing on a selective medium (EbSA; AlphaO-
mega, The Hague, The Netherlands) was performed using matrix-assisted
laser desorption ionization–time of flight (MALDI-TOF) (bioMérieux,
Marcy l’Etoile, France). Susceptibility testing was performed by Vitek2
(bioMérieux), and ESBL production was confirmed by the double-disk
method. For all phenotypically ESBL-positive isolates, ESBL genes were
detected using a commercial microarray (Check-MDR CT103; Check-
points, Wageningen, The Netherlands) that was used as the gold standard
(9, 10) This assay identifies the -lactamase genes of TEM, SHV, and
CTX-M and is able to detect single nucleotide polymorphisms (SNPs) in
TEM and SHV genes, thus discriminating between ESBL and non-ESBL
TEM and SHV variants. In addition, the assay can detect pAmpC (CMY-
2-like, DHA, FOX, ACC-1, ACT/MIR, and CMY-1-like/MOX) and car-
bapenemases (KPC, OXA-48, VIM, IMP, and NDM). In cases in which
resistance genes were detected by microarray but not by the BioDetection
system, the microarray was repeated for these isolates. All ESBL-positive
isolates were stored at minus 80 degrees for subsequent typing. Typing
was performed on all 56 E. coli isolates included in the collection.
Amplified fragment length polymorphism (AFLP). AFLP was per-
formed as described by Mohammadi et al. (VU Medical Centre, Amster-
dam, The Netherlands) (11). Briefly, DNA was isolated using a QIAamp
DNA minikit (Qiagen). The restriction-ligation reaction mixtures con-
sisted of approximately 10 ng DNA, 1 T4 DNA ligase buffer, 0.05 M
NaCl, 0.5 g bovine serum albumin (BSA), 1 pmol of the EcoRI adapter,
10 pmol of the MseI adapter (Eurogentec, Maastricht, The Netherlands),
80 U of T4 DNA ligase, 1 U of EcoRI, and 1 U of MseI. All enzymes were
purchased from New England BioLabs (Beverly, MA). After incubation at
37°C for 3 h, the mixtures were diluted 1:20 in water. A 5-l volume of the
mixture was added to 5 l of PCR mixture, which consisted of 1 PCR
buffer (Sphaero Q; Gorinchem, The Netherlands), 200M deoxynucleo-
side triphosphates (dNTPs) (Promega), 1 U Super Taq polymerase (Spha-
ero Q), and 20 ng of Eco-A primer and 60 ng of Mse-C primer. The Eco-A
primer was fluorescently labeled with carboxyfluorescein (Eurogentec).
Amplification was carried out under the following conditions: 2 min at
72°C, followed by 12 cycles of 30 s at 94°C, 30 s at 65°C, and 1 min at 72°C
and then 23 cycles of 30 s at 94°C, 30 s at 56°C, and 1 min at 72°C.
Amplification was ended by a single extension at 72°C for 1 min. A 2.5-l
volume of each PCR product was added to 22l Hi-Di formamide and 0.5
l GeneScan-600 LIZ size standard (Applied Biosystems). Fragments
were separated on an ABI Prism 3130 sequencer (Applied Biosystems).
Data were analyzed with GENESCAN analysis software (Applied Biosys-
tems) and the BioNumerics software package, version 6.6 (Applied Maths,
Sint-Martens-Latem, Belgium). Similarity coefficients were calculated
with Pearson correlation, and dendrograms were obtained by the un-
weighted pair group method using arithmetic averages (UPGMA) for
clustering. The analysis was performed for fragments with lengths of be-
tween 60 and 600 bp. Isolates were considered indistinguishable (repre-
senting a cluster) when the band patterns were identical.
Hospital-acquired infection (HAI) BioDetection System. The
pathogens that can be detected by the HAI BioDetection System (Patho-
genica, Boston, MA) are Acinetobacter baumannii, Acinetobacter pittii,
Acinetobacter calcoaceticus, Clostridium difficile, Escherichia coli, Entero-
coccus faecalis, Enterococcus faecium, Enterobacter aerogenes, Enterobacter
cloacae, Klebsiella oxytoca, Klebsiella pneumoniae, Proteus mirabilis, Pseu-
domonas aeruginosa, Staphylococcus aureus, Staphylococcus epidermidis,
Staphylococcus saprophyticus, and Staphylococcus haemolyticus. The drug
resistance genes that can be detected by the HAI BioDetection System are
NDM, OXA, KPC, IMP, CARB, CMY, CTX-M, TEM, SHV, PER, VEB,
and VIM (beta-lactamases), mecA (methicillin resistance), vanA (glyco-
peptide resistance), ermA (macrolide/lincosamide resistance), and mexA
(multidrug resistance efflux operon). In addition to the genes mentioned
here, which are all listed in the product brochure, the assay can also detect
several aminoglycoside resistance genes (aac, aad, and ant) and sulfon-
amide resistance genes (sul1) (Table 1). The probe set may not detect all
forms of these genes, however, and the detection of these genes has not yet
been validated.
The assay is based on approximately 300 probes that capture and am-
plify short DNA regions of interest that were selected by the manufacturer
based on previously performed whole-genome analyses. The kit simulta-
neously sequences all probe targets from any organism in a sample, min-
imizing the hands-on time needed to identify and type bacterial species,
while detecting resistance genes at the same time. By targeting variable
regions, the selected probe set can identify species and distinguish be-
tween strains while sequencing only a few kilobases of a genome.
Isolates were thawed, DNA was extracted, and each sample was diluted
to a working DNA concentration of 0.5 ng/l and processed further,
according to the instructions of the manufacturer. Individually barcoded
isolates were combined into a clean microcentrifuge tube, and this pooled
PCR product was purified using 0.8 Agencourt AMPure XP Reagent
(Beckman Coulter). An Ion Torrent PGM sequencing platform (Life
Technologies) was used to sequence the DNA fragments. Template prep-
aration was carried out with an Ion PGM Template OT2 200 kit (Life
Technologies), according to the instructions of the manufacturer. Se-
quencing data were analyzed using an internal version of Pathogenica’s
HAI BioDetection software v1.2. This software uses 103 to 106 sequencing
reads to determine the genomic sequence of all of the loci targeted by the
assay for each organism present in the sample. RAxML was used to gen-
erate a phylogenetic tree for the samples (12). A shell-scripting interface to
the software (rather than the Torrent Server interface) was used to create
the tree, whereby the probe weight and partition values were shown to be
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identical to those present in software v1.2. After tree construction, each
tree’s leaves were ordered using an optimal leaf-ordering algorithm (13)
to make clusters easier to identify by eye. All analyses were performed
without knowledge of the species determination, resistance phenotype, or
AFLP results. The time from DNA isolation to results was approximately
12 h.
WGS analysis. Using the same DNA as was used with the BioDetec-
tion kit, we performed whole-genome sequencing using an Illumina
MiSeq system. Reads were aligned to the Escherichia coli NA114 genome
(GenBank accession number CP002797) using the Bowtie2 aligner (ver-
son 2.1.0) in paired-end mode with parameters “–sensitive –minins 10
–maxins 1400” and a “–rg-id” parameter to store the sample name in the
alignment output. We then sorted and merged all of the output files to
generate a single BAM file with all aligned reads and used FreeBayes (ver-
sion 0.9.9.2-14) on that file to generate a VCF file of SNP calls. We filtered
the SNP calls to include only those with 10 reads of coverage and at least 5
reads supporting the call. If SNPs could be called in some samples, then
the other samples were included as “-” for missing data. We then gener-
ated FASTA and PHYLIP files using only genomic loci at which at least
one sample showed a SNP. The PHYLIP file was used as the input to
RaxML to generate the whole-genome-sequencing (WGS) phylogenetic
trees with parameters “-T 16 -p $$ -f a -s ${project}.phylip -n
${project}.raxml-gtrgamma.tree -m GTRGAMMA -x $$ -N autoMRE
-k.” We generated trees both for the full set of samples and for a subset of
more closely related samples. Due to our input format, which contained
only variant genomic loci, the tree distances do not measure a true dis-
tance (i.e., SNPs/genome size) but rather a relative value (i.e., SNPs/num-
ber of variant loci). Trees were optimized for display using the same op-
timal leaf ordering as was used for the BioDetection trees.
Phylogrouping and ST131 PCR. To support the interpretation of the
2 typing methods mentioned above, we also performed PCRs to detect
ST131-specific sequences and to assign the isolates to one of the E. coli
phylogroups. E. coli consists of 8 genetic subspecies (phylogroups) that
differ in their levels of virulence and ecological niches, according to which
phylogroups B2 and D are more likely to cause extraintestinal infection
than the other phylogroups (14). Phylogroup B2 has been associated with
E. coli ST131. We used a real-time PCR to detect single nucleotide poly-
morphisms specific for the MLST clone ST131 as described by Dhanji et
al. (15) This assay amplifies the regions within the pabB gene that contain
the ST131-specific SNPs (adenine-450 and thymine-144) by melting
curve analysis. Using the isolates that were classified as ST131 on the basis
of the PCR results, multilocus sequence typing (MLST) was performed on
1 “representative” isolate, according to methods described previously by
Wirth et al. (16). Phylogrouping of all E. coli strains was done by a multi-
plex PCR that targets 3 phylogenetic group marker genes and one control
gene (yjaA, chuA, tspE, and gadA). Polymorphisms in these genes were
detected as described by Doumith et al. (17).
Comparison of the typing results. First, we visually assessed the
agreement of the phylogenetic tree generated by the HAI BioDetection kit
software with the results generated by AFLP. We also assessed to what
extent the arrangement of this tree was concordant with the available
epidemiological data.
In addition, whole-genome sequencing was performed for a selected
set of isolates (for specification of the isolates; see Results). Samples were
selected to reflect the inherent genetic diversity of the sample set and to
cover the breadth of AFLP clusters but also to include pairs that were
closely related according to the BioDetection data but that seemed unre-
lated based on AFLP. Genomic DNA for these samples was prepared for
sequencing using a Nextera kit (Illumina) and sequenced using a 2 
150-bp kit on the MiSeq platform (Illumina).
RESULTS
Typing. Among the 56 E. coli isolates, five clusters of isolates were
identified by AFLP, and 12 isolates were considered unique. The
largest cluster consisted of 31 indistinguishable isolates (5 repre-
sentatives in green), whereas the other 4 clusters included only 3
or 4 indistinguishable isolates (yellow, blue, pink, and red; Fig. 1).
Isolates from the green cluster were exclusively found in depart-
ments in buildings B and C in nursing home 1. Isolates unrelated
to this cluster were not found in these departments. The smaller
clusters were found in department A1 (red cluster), in department
A2 (pink and blue clusters) in nursing home 1, and in department
D1 (yellow cluster) in nursing home 2. Results related to the AFLP
typing, ST131 PCR, and department of residence at the time of
sample collection are indicated in Fig. 1. All isolates from the green
cluster belonged to phylogroup B2 and were found to be ST131 by
PCR. For one isolate representative of this cluster, sequence type
results were confirmed by MLST.
The HAI BioDetection kit correctly identified 54 isolates as E.
coli. Due to technical problems with the sample, sequence results
TABLE 1 Resistance genes detected by microarray (Check-MDR CT103, Checkpoints) and by the HAI BioDetection System
Detection method
No. of isolates with ESBL genes (n 54 E. coli isolates)a
CTX-M-1 (n 8) CTX-M-3 (n 1) CTX-M-15 (n 32) CTX-M-9 (n 6) TEM (n 7)
Microarray
Non-ESBL TEM positive 4 1 1 3 0
Non-ESBL TEM negative 4 0 31 3 7
HAI BioDetection system
Beta-lactamase genes
CTX-M 7 1 32 6 0
TEMb 4 1 1 2 7
Other resistance genesc
aac(6=)-Ib 0 0 28 4 0
ant 0 1 5 5 0
ant(3=)-Ia 1 1 0 3 1
sul1 0 0 0 2 0
a Results are missing for the HAI BioDetection system for 2 isolates; these were not included in the table.
b The assay was unable to discriminate between ESBL and non-ESBL TEM beta-lactamases. ESBL TEM was not present in any of the isolates with CTX-M beta-lactamases: for
isolates with CTX-M-1, CTX-M-3, CTX-M-15, and CTX-M-9, microarray analysis detected non-ESBL TEM genes in 4, 1, 1, 3, and 0 isolates, respectively. The HAI BioDetection
kit failed to detect 1 CTX-M gene and 1 non-ESBl TEM gene: the microarray analysis was repeated for these isolates.
c aac(6=)-Ib encodes aminoglycoside N-acetyltransferase, which modifies aminoglycosides by acetylation. ant and ant(3=)-Ia encode aminoglycoside O-nucleotidylyltransferase.
Some probes can distinguish between Ant forms (e.g., Ant3Ia); others only give the family identification (ant). sul1 encodes sulfonamide-resistant dihydropteroate synthase.
Veenemans et al.
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could not be generated for 2 isolates. Figure 2 shows the phyloge-
netic tree produced by the HAI BioDetection v1.2 software. For
each isolate, the AFLP cluster is indicated by its designated color in
the figure, followed by the department designation. As shown in
the figure, the BioDetection phylogenetic tree shows strong relat-
edness for all isolates belonging to the green AFLP cluster,
whereby 5 strains in the cluster, 4 from department B2 and 1 from
department C1, appeared in a slightly separate location in the tree.
The arrangement of other parts of the phylogenetic tree also
largely agreed with the clusters defined by AFLP and with the
epidemiological data.
For several isolates, the results of the two typing methods
yielded discordant interpretations. Specifically, there were 2 pa-
tients (P1 and P3; see Fig. 2) who carried an ESBL E. coli strain
during both consecutive surveys and for whom the isolates col-
lected in March belonged to the green (P1) and the red (P3) clus-
ter, whereas AFLP unexpectedly resulted in unique signatures for
the isolates of both patients collected in May. In the BioDetection
phylogenetic tree, these isolates showed only minor divergence,
and in-depth assessment of the NGS results showed a difference of
34 SNPs for the 2 isolates from patient P3 and a difference of 78
SNPs for the 2 isolates from patient P1. It should be noted that for
the isolates from patient P1, inspection of the AFLP patterns re-
vealed only minor differences (Pearson’s similarity index of about
90%; see Fig. 1 [the isolates from P1 are indicated by WGS 27 and
WGS 52]).
Whole-genome sequencing (WGS) was performed on a subset
of 11 isolates, indicated by arrows in Fig. 2. This subset included
the 4 isolates collected from the 2 patients (P1 and P3) described in
the previous paragraph and 2 isolates from another patient (P2;
isolates 27 and 52, both from the yellow cluster, collected in March
and May [see Fig. 2]). WGS was also performed on 5 isolates with
various positions in the HAI tree to determine the genetic diversity
in the isolate collection: 1 isolate from the blue AFLP cluster (iso-
late 51) and a set of 4 isolates from the green AFLP cluster, of
which 2 isolates (12 and 25) appeared in a slightly separate
“group” in the HAI tree (see Fig. 2).
WGS results are shown in Fig. 3. As predicted by the placement
in the HAI BioDetection tree and AFLP results and shown in panel
A of the figure, WGS data from isolates 44 and 46 (P3) and isolate
51 (blue cluster) show substantial divergence from those from the
other 8 isolates. To better examine the relationships among those
8 isolates, we generated a new WGS tree with higher resolution
using this subset; these results are shown in panel B. In this new
tree, the ordering of the 4 isolates from the green cluster (53 plus
55 versus 12 plus 25) was consistent with the HAI phylogenetic
tree, and the 2 pairs of samples of patient P1 (41 plus 11) and P2
(52 plus 27) were presented as expected.
FIG 1 Results of amplified fragment length polymorphism (AFLP) analysis. The colors indicate the clusters determined by amplified fragment length polymor-
phism (AFLP) analysis. Isolates without a color are those considered unique isolates. For the largest cluster (green; 31 isolates), only 5 isolates are presented in the
figure for practical reasons. The columns on the right side of the figure indicate (per isolate row) the results of the microarray analysis (resistance genes), the
location of isolate collection (NH1 or NH2, followed by the department), and the results of the phylogroup and ST131 PCR analyses. The numbers (in gray boxes)
on the far right indicate the WGS isolate number and correspond to the WGS numbers presented in Fig. 2 and 3. NT, not determined.
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Lastly, we examined the association between the number of
SNPs observed between sample pairs (55 pairs for 11 samples with
WGS data) by the HAI BioDetection data and the (log-trans-
formed) number of SNPs between the same sample pairs in the
WGS data. This confirmed the correlation between the number of
SNP differences detected by the BioDetection System and the true
genomic distance (Pearson’s correlation coefficient, 0.69; P 
0.01).
Detection of resistance genes. An overview of the resistance
genes detected by the 2 assays is provided in Table 1. CTX-M
and TEM ESBL beta-lactamases were detected by microarray in
47/54 and 7/54 isolates, respectively. SHV genes were not de-
tected. The HAI BioDetection System did not detect the
CTX-M beta-lactamase gene for 1 isolate (CTX-M-1; see Table
1 [sensitivity, 98%]) and was not able to discriminate between
the genes from the different CTX-M groups. TEM beta-lacta-
mase genes were detected by microarray in 16 isolates (TEM
wild type [TEM-WT], 9 isolates; TEM-ESBL, 7 isolates), while
the HAI BioDetection kit found TEM beta-lactamase gene in 15
isolates (8 TEM-WT and 7 TEM-ESBL), whereby no discrimi-
nation was provided between ESBL and non-ESBL TEM beta-
lactamase genes. An overview of other resistance genes that
were detected by the kit is provided in Table 1. aac(6=)-Ib (en-
coding aminoglycoside N-acetyltransferase, which modifies
aminoglycosides by acetylation) was found in 32 isolates and
was found more frequently among isolates carrying CTX-M-15
(28/32) than among isolates with other CTX-M genes (4/22)
(P  0.01; Fisher’s exact text). Of the isolates carrying the
aac(6=)-Ib gene, 21 (66%) were resistant to tobramycin, while
FIG 2 Phylogenetic tree generated by the HAI BioDetection system in combination with AFLP results. The five AFLP clusters are indicated by colors for each
isolate. Isolates considered unique by AFLP are indicated in white. The location of residence (nursing home location NH1 and NH2, building A, B, C, or D, or
Department 1, 2, or 3) is indicated in capitals to the right of each circle representing an isolate. Arrows indicate isolates for which whole-genome sequencing was
performed. P1, P2, and P3 refer to patients 1, 2, and 3. The scale at the bottom indicates substitutions per site relative to the 10 kb of sequence included in the
analysis by the kit.
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the 11 remaining isolates (34%) showed intermediate suscep-
tibility.
DISCUSSION
In this collection of 56 E. coli isolates, the BioDetection phyloge-
netic tree correctly reflected the strong relatedness of all isolates
belonging to the large outbreak cluster identified by AFLP, as well
as the relatedness of isolates belonging to the smaller AFLP clus-
ters. It should be noted that the discordant results for several iso-
lates may be partly due to the fact that the assays were not per-
formed simultaneously on the same culture. For the isolates that
were analyzed by whole-genome sequencing, the results indicate
that, although the BioDetection system sequences only a small
part of the genome, the number of SNPs reported is predictive of
the true genomic divergence as determined by WGS.
A limitation of the version of the HAI BioDetection software
that was used is that it did not translate the typing results into a set
of distinct clusters. To facilitate the interpretation of the typing
results, further work on the definition of species-specific cutoffs is
currently under way to improve the software so that clusters can
be defined in a standardized way. Finally, although the test collec-
tion included a considerable number of E. coli isolates and con-
sisted of several separate AFLP clusters with distinct epidemiolog-
ical backgrounds, an evaluation of the typing performance with a
larger collection (that reflects the diversity present among the
members of the species as a whole) is justified.
The BioDetection assay accurately detected resistance genes in
all but 1 CTX-M-positive isolate (sensitivity 98%), but it was un-
able to discriminate between ESBL and non-ESBL TEM and SHV
beta-lactamases or to specify CTX-M genes by group. When the
assay is used to screen direct patient material for the presence of
resistance genes, an additional test is thus required in case of a
positive test result. This is particularly true for TEM and SHV
genes but may also be useful when CTX-M genes are detected, as
discriminating between different groups of resistance genes is im-
portant for epidemiological purposes. We have no data about the
prevalence of non-ESBL TEM genes in direct fecal material of the
patients in this collection, as a selective culture step preceded the
DNA isolation. With regard to the failure of the kit to detect an
ESBL CTX-M gene for 1 isolate, we cannot exclude the possibility
that plasmids carrying the resistance gene were lost during stor-
age, a phenomenon that has been described previously (18). As
reported by others (19), the aac(6=)-Ib gene coding for the amin-
oglycoside-modifying enzyme was found in almost all ST131 iso-
lates.
In conclusion, the performance of the HAI BioDetection Sys-
tem for typing of E. coli isolates compared well with the results of
AFLP. Its performance in larger collections from different loca-
tions and for typing of other species was not evaluated and needs
further study. A recent study showed accurate discrimination of
clonal lineages in a collection of 32 carbapenem-resistant Kleb-
siella pneumoniae isolates (20). Its ease of use, the ability to simul-
taneously detect resistance genes, and the potential to create an
electronic database for surveillance are important advantages. Al-
though the assay has good sensitivity to detect resistance genes and
can be used to screen for their presence, TEM and SHV genes
would need to be characterized further by an additional test.
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